| Date Filed | Type | Description |
| 02/10/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2012 |
SC 13G/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 0% stake in Icagen, Inc. |
| 11/07/2011 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/02/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/02/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/28/2011 |
8-K
| Quarterly results |
| 10/27/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 10/27/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/27/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/27/2011 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 10/07/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/06/2011 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 09/26/2011 |
PRE 14C
| Form PRE 14C - Other preliminary information statements |
| 09/22/2011 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/20/2011 |
SC 13D/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/16/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 09/13/2011 |
SC 13D/A
| ICAGEN INC has filed a Schedule 13D for ICAGEN, INC. |
| 09/09/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 09/07/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 09/06/2011 |
8-K
| Changes in Control of Registrant, Financial Statements and Exhibits |
| 09/06/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/02/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/01/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 09/01/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/29/2011 |
GN
| Icagen Reaffirms Recommendation to Shareholders to Tender Shares |
| 08/26/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/26/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/19/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/16/2011 |
GN
| Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share |
| 08/12/2011 |
10-Q
| Quarterly Report for the period ended June 30, 2011 |
| 08/11/2011 |
SC 13D/A
| Merlin BioMed Private Equity Advisors, L.L.C. reports a 8.5% stake in ICAGEN, INC. |
| 08/11/2011 |
SC 13D/A
| New Leaf Ventures II, L.P. reports a 2.3% stake in Icagen, Inc. |
| 08/10/2011 |
8-K
| Quarterly results |
| 08/03/2011 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
|